As the cost of bringing new drugs to market continues to grow so does the pressure to increase efficiency and productivity throughout the development cycle.
Speed to decision is critical. You need to rapidly evaluate potential candidate compounds and confidently assess their effectiveness as therapeutic drugs. Agilent can help meet your needs in drug discovery with high throughput automated systems for compound identification in early discovery and with sophisticated, highly sensitive analytical systems that can provide quick answers to routine questions—for both expert users and trained technicians.
Developing small molecule pharmaceuticals requires efficient processes together with an evaluation of safety and efficacy. You have to make critical decisions from a variety of compound assessments - and you need to be absolutely confident that you’re making the right choice. Agilent solutions for ADME/PK, purification, impurities analysis, method development, and quality by design (QbD) provide the answers and efficiency you need with the reliability you expect from Agilent.
We understand that, in manufacturing and quality control, productivity and compliance are critical, and we have solutions to help you:
- Identify incoming raw materials
- Monitor volatile, semi-volatile, or non-volatile impurities
- Evaluate dissolution properties
- Determine content uniformity
Agilent understands your needs in pharmaceutical discovery, development, manufacturing, and quality control and has sample-to-data solutions that work together seamlessly. Let us help you rapidly move new pharmaceutical candidates toward approval and to patients
Follow Agilent’s Pharma LinkedIn Showcase:
Follow us on LinkedIn for continuous up to date Pharma news, events, publications